TrialDiabetes, obesity & metabolism2018

Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes.

Carol H Wysham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.